A bioactive nano-calcium phosphate paste for in-situ transfection of BMP-7 and VEGF-A in a rabbit critical-size bone defect: results of an in vivo study
- 22 January 2019
- journal article
- research article
- Published by Springer Nature in Journal of Materials Science: Materials in Medicine
- Vol. 30 (2) , 15
Abstract
The aim of this study was to prepare an injectable DNA-loaded nano-calcium phosphate paste that is suitable as bioactive bone substitution material. For this we used the well-known potential of calcium phosphate in bone contact and supplemented it with DNA for the in-situ transfection of BMP-7 and VEGF-A in a critical-size bone defect. 24 New Zealand white rabbits were randomly divided into two groups: One group with BMP-7- and VEGF-A-encoding DNA on calcium phosphate nanoparticles and a control group with calcium phosphate nanoparticles only. The bone defect was created at the proximal medial tibia and filled with the DNA-loaded calcium phosphate paste. As control, a bone defect was filled with the calcium phosphate paste without DNA. The proximal tibia was investigated 2, 4 and 12 weeks after the operation. A histomorphological analysis of the dynamic bone parameters was carried out with the Osteomeasure system. The animals treated with the DNA-loaded calcium phosphate showed a statistically significantly increased bone volume per total volume after 4 weeks in comparison to the control group. Additionally, a statistically significant increase of the trabecular number and the number of osteoblasts per tissue area were observed. These results were confirmed by radiological analysis. The DNA-loaded bone paste led to a significantly faster healing of the critical-size bone defect in the rabbit model after 4 weeks. After 12 weeks, all defects had equally healed in both groups. No difference in the quality of the new bone was found. The injectable DNA-loaded calcium phosphate paste led to a faster and more sustained bone healing and induced an accelerated bone formation after 4 weeks. The material was well integrated into the bone defect and new bone was formed on its surface. The calcium phosphate paste without DNA led to a regular healing of the critical-size bone defect, but the healing was slower than the DNA-loaded paste. Thus, the in-situ transfection with BMP-7 and VEGF-A significantly improved the potential of calcium phosphate as pasty bone substitution material.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (EP 22/39-1)
- Deutsche Forschungsgemeinschaft (LE 1298/3-1)
This publication has 79 references indexed in Scilit:
- Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: A reviewActa Biomaterialia, 2012
- Use and efficacy of bone morphogenetic proteins in fracture healingInternational Orthopaedics, 2011
- Barriers to Non-Viral Vector-Mediated Gene Delivery in the Nervous SystemPharmaceutical Research, 2011
- Delivery of siRNA Therapeutics: Barriers and CarriersThe AAPS Journal, 2010
- Evaluation of a novel nanocrystalline hydroxyapatite paste Ostim® in comparison to Alpha-BSM® - more bone ingrowth inside the implanted material with Ostim® compared to Alpha BSM®BMC Musculoskeletal Disorders, 2009
- The Dose of Growth Factors Influences the Synergistic Effect of Vascular Endothelial Growth Factor on Bone Morphogenetic Protein 4–Induced Ectopic Bone FormationTissue Engineering Part A, 2009
- The Synergistic Effect of Autograft and BMP-7 in the Treatment of Atrophic NonunionsClinical Orthopaedics and Related Research, 2009
- Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect modelBone, 2008
- Biomaterials in orthopaedicsJournal of The Royal Society Interface, 2008
- Nonviral gene transfection nanoparticles: function and applications in the brainNanomedicine: Nanotechnology, Biology and Medicine, 2008